First Time Loading...

F-Star Therapeutics Inc
NASDAQ:FSTX

Watchlist Manager
F-Star Therapeutics Inc Logo
F-Star Therapeutics Inc
NASDAQ:FSTX
Watchlist
Price: 7.12 USD Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

83.7m
-17%
Assets
Growth Rates:
1 Year
-27%
3 Years
+19%
5 Years
+55%
7 Years
+430%
10 Years
-
26.8m
-8%
Liabilities
Growth Rates:
1 Year
+8%
3 Years
-4%
5 Years
+22%
7 Years
+2 060%
10 Years
-
56.9m
-21%
Equity
Growth Rates:
1 Year
-37%
3 Years
+34%
5 Years
+78%
7 Years
+291%
10 Years
-

Balance Sheet Decomposition
F-Star Therapeutics Inc

83.7m
Assets
26.8m
Liabilities
83.7m
Assets
26.8m
Liabilities
Current Assets 49.6m
Cash & Short-Term Investments 35.6m
Receivables 8.1m
Other Current Assets 5.9m
Non-Current Assets 34.1m
PP&E 3.4m
Intangibles 30.3m
Other Non-Current Assets 412k
Current Liabilities 14.7m
Accounts Payable 2.5m
Accrued Liabilities 8.6m
Other Current Liabilities 3.6m
Non-Current Liabilities 12.1m
Long-Term Debt 8.5m
Other Non-Current Liabilities 3.6m

Balance Sheet
F-Star Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
6
2
4
11
24
15
29
19
79
Cash Equivalents
6
2
4
11
24
15
29
19
79
Short-Term Investments
0
0
5
14
27
33
26
0
0
Total Receivables
0
12
0
0
0
0
0
4
2
Other Current Assets
1
1
0
1
1
2
4
4
4
Total Current Assets
7
14
10
26
51
49
58
26
85
PP&E Net
0
0
0
1
1
2
5
4
4
PP&E Gross
0
0
0
0
1
2
5
4
4
Accumulated Depreciation
0
0
0
0
0
0
1
1
2
Intangible Assets
0
0
0
0
0
0
0
19
19
Goodwill
0
0
0
0
0
0
0
15
15
Long-Term Investments
0
0
3
1
0
17
0
0
0
Other Long-Term Assets
0
0
1
0
1
0
0
0
0
Other Assets
0
0
0
0
0
0
0
15
15
Total Assets
8
N/A
14
+81%
15
+6%
27
+84%
52
+95%
69
+31%
63
-8%
64
+1%
123
+93%
Liabilities
Accounts Payable
0
0
2
2
2
2
2
5
3
Accrued Liabilities
1
1
1
2
3
2
3
10
7
Short-Term Debt
4
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
2
2
Total Current Liabilities
5
2
4
4
4
4
5
17
12
Long-Term Debt
0
0
0
0
0
0
19
0
10
Deferred Income Tax
0
0
0
0
0
0
0
1
0
Other Liabilities
0
0
0
6
13
9
3
3
4
Total Liabilities
5
N/A
2
-66%
4
+120%
10
+178%
18
+78%
13
-26%
28
+114%
21
-25%
26
+27%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
Retained Earnings
13
23
34
52
79
102
126
47
78
Additional Paid In Capital
16
35
45
69
114
158
162
91
177
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
1
0
Other Equity
0
0
0
0
0
0
0
0
2
Total Equity
3
N/A
12
+319%
11
-10%
17
+54%
35
+104%
56
+61%
36
-36%
43
+21%
97
+125%
Total Liabilities & Equity
8
N/A
14
+81%
15
+6%
27
+84%
52
+95%
69
+31%
63
-8%
64
+1%
123
+93%
Shares Outstanding
Common Shares Outstanding
2
2
2
2
3
4
4
9
21

See Also

Summary
FSTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
FSTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FSTX stock valuation using valuation multiples.
Wall Street Estimates
FSTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FSTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.